| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.8 |
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.8 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.0071 | 0.8 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.0088 | 0.8 |
| mRNA | ATRA | FIMM | pan-cancer | AAC | -0.03 | 0.8 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | -0.0077 | 0.8 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.009 | 0.8 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | 0.015 | 0.8 |
| mRNA | ETP-46464 | CTRPv2 | pan-cancer | AAC | 0.0085 | 0.8 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | -0.0073 | 0.8 |